Found: 23
Select item for more details and to access through your institution.
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 389, doi. 10.3390/ph13110389
- By:
- Publication type:
- Article
Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation.
- Published in:
- Hereditary Cancer in Clinical Practice, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s13053-020-00155-w
- By:
- Publication type:
- Article
Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30765-y
- By:
- Publication type:
- Article
Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1385094
- By:
- Publication type:
- Article
Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1276729
- By:
- Publication type:
- Article
Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2497, doi. 10.1007/s00262-021-02875-x
- By:
- Publication type:
- Article
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 3083, doi. 10.3390/cancers16173083
- By:
- Publication type:
- Article
The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5305, doi. 10.3390/cancers14215305
- By:
- Publication type:
- Article
Melanoma Targeted Therapies beyond BRAF -Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5847, doi. 10.3390/cancers13225847
- By:
- Publication type:
- Article
Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3164, doi. 10.3390/cancers13133164
- By:
- Publication type:
- Article
Novel immunotherapeutic options for BCG‐unresponsive high‐risk non‐muscle‐invasive bladder cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 24, p. 21944, doi. 10.1002/cam4.6768
- By:
- Publication type:
- Article
The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Survival outcomes in patients with de novo metastatic Merkel cell carcinoma according to site of metastases.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1444590
- By:
- Publication type:
- Article
Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review).
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 6, p. N.PAG, doi. 10.3892/ijo.2022.5359
- By:
- Publication type:
- Article
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1244, doi. 10.1159/000509744
- By:
- Publication type:
- Article
Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 2, p. 911, doi. 10.1159/000508933
- By:
- Publication type:
- Article
Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. 1202, doi. 10.1111/jdv.19907
- By:
- Publication type:
- Article
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 102, n. 6, p. 1208, doi. 10.4269/ajtmh.20-0266
- By:
- Publication type:
- Article
Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 2, p. e80, doi. 10.1111/1346-8138.15621
- By:
- Publication type:
- Article
Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2021, v. 7, n. 5, p. 1, doi. 10.1101/mcs.a006129
- By:
- Publication type:
- Article
Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.978996
- By:
- Publication type:
- Article
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.576314
- By:
- Publication type:
- Article